6th annual Japanese Regenerative Medicine Symposium
PLENARY Session : Wednesday, January 24, 2018
9:00-11:00 AM
Japan has a fully integrated plan to advance and accelerate regenerative medicine products. Key Japanese leaders from academia, industry and government will present at this must-attend for anyone seeking to gain first-hand knowledge and insight into what is happening in Japan.
Recent Progress of Industry-Academia Open Innovation in Japan for Cell Application
- Chair’s Introduction Takashi Asada, PhD, Kyoto University
- Keynote Address Hideyuki Okano, MD, PhD Professor & Dean, Keio University Medical School; Director of the Japanese Society for Regenerative Medicine
- Keynote Address Akihiko Iwai, PhD Vice President, Astellas Pharma, Inc.; Vice Chairman, Forum for Innovative Regenerative Medicine (FIRM)
- Regulator’s Perspective Yoji Sato, PhD, Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences (Japan)
- Masato Ibuki, Assistant Manager (Senior Research Scientist), Regenerative Medicine and Cell Therapy Laboratories, Health Care Solutions Research Institute, Kaneka Corporation
- Roundtable discussion Featuring speakers of the session, plus:
– Prof. Norio Nakatsuji, Professor Emeritus, Kyoto University;
– Masato Ibuki, Regenerative Medicine and Cell Therapy Laboratories, KANEKA Corporation;
– Masayo Yumoto, PhD, Group Leader, Basic Research Group, Regenerative Medicine Research & Planning Division, Rohto Pharmaceutical, Co., Ltd